Novel Niacin Receptor Agonists: A Promising Strategy for the Treatment of Dyslipidemia.

Kothawade, Prajakta B; Thomas, Asha B; Chitlange, Sohan S

Kothawade, Prajakta B; Thomas, Asha B; Chitlange, Sohan S.

Affiliation

Kothawade PB; Department of Pharmaceutical Chemistry, Dr. D. Y. Patil Institute of Pharmaceutical Science and Research, Pimpri, Pune, Maharashtra, India - 411 018 (Affiliated to SPPU, Pune), India.
Thomas AB; Department of Pharmaceutical Chemistry, Dr. D. Y. Patil Institute of Pharmaceutical Science and Research, Pimpri, Pune, Maharashtra, India - 411 018 (Affiliated to SPPU, Pune), India.
Chitlange SS; Department of Pharmaceutical Chemistry, Dr. D. Y. Patil Institute of Pharmaceutical Science and Research, Pimpri, Pune, Maharashtra, India - 411 018 (Affiliated to SPPU, Pune), India.

Mini Rev Med Chem ; 21(17): 2481-2496, 2021.

Article in En | MEDLINE | ID: mdl-33550969

Subject(s)
Key words

Antihyperlipidemic drugs; G-protein coupled receptor (GPCR); HDL.; Niacin receptor agonists; cutaneous flushing; dyslipidaemia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, G-Protein-Coupled / Dyslipidemias / Niacin Limits: Humans Language: En Journal: Mini Rev Med Chem Journal subject: QUIMICA Year: 2021 Document type: Article Affiliation country: India Country of publication: Países Bajos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google